July 10, 2020
Proteus Digital Health, makers of an ingestible sensor embedded within a pill to track medication usage, has filed for bankruptcy after failing to raise funding. […]
July 10, 2020
Takeda is set to spend nearly $1B in backloaded payments for a deal with startup Carmine Therapeutics. They will target rare diseases using gene therapies out […]
July 10, 2020
After the deaths of George Floyd, Ahmaud Arbery, and Breonna Taylor, Americans have spoken up about racial inequalities, police violence, and systemic racism. Biopharma leaders are […]
July 24, 2020
FierceBiotech has compiled a list of the top 10 highest paid biopharma R&D executives in 2019. Although one might think that the companies with the biggest […]
August 21, 2020
Genentech is letting go 474 staffers on the West Coast. Most of the 474 employees will be gone by September 18, with all gone by October. […]
August 21, 2020
Biogen plans to spend more than $1B to access experimental Parkinson’s disease drugs and take an equity stake in their developer, Denali Therapeutics. Denali’s most advanced […]
August 21, 2020
So far this year, U.S.-listed biotech companies have raised roughly $9.4 billion in initial public offerings, already beating the $6.5 billion raised in all of 2018, […]
August 21, 2020
Johnson & Johnson has struck a deal to buy Momenta Pharmaceuticals for $6.5B, giving J&J control of an anti-FcRn antibody that completed a phase 2 trial […]
August 21, 2020
While Biogen’s top products are facing tough competition and the biotech is trying to secure approval for what could be a first-of-its-kind Alzheimer’s disease drug, the […]